Russell Investments Group Ltd. Lifted Holding in CME Group Inc (CME)

Russell Investments Group Ltd. boosted its stake in shares of CME Group Inc (NASDAQ:CME) by 53.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 615,226 shares of the financial services provider’s stock …

Russell Investments Group Ltd. boosted its stake in shares of CME Group Inc (NASDAQ:CME) by 53.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 615,226 shares of the financial services provider’s stock after buying an additional 214,893 shares during the period. Russell Investments Group Ltd. owned about 0.18% of CME Group worth $73,097,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Huntington National Bank boosted its position in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the period. Johnson Financial Group Inc. boosted its position in shares of CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock valued at $104,000 after buying an additional 50 shares during the period. Parallel Advisors LLC bought a new position in shares of CME Group during the fourth quarter valued at about $120,000. Archford Capital Strategies LLC boosted its position in shares of CME Group by 5,492.0% in the fourth quarter. Archford Capital Strategies LLC now owns 1,398 shares of the financial services provider’s stock valued at $161,000 after buying an additional 1,373 shares during the period. Finally, Advisors Preferred LLC bought a new position in shares of CME Group during the third quarter valued at about $180,000. 80.06% of the stock is owned by institutional investors and hedge funds.

CME Group Inc (NASDAQ:CME) traded up 0.93% during trading on Friday, reaching $116.19. The company’s stock had a trading volume of 1,904,593 shares. CME Group Inc has a 52 week low of $92.00 and a 52 week high of $127.60. The stock has a market capitalization of $39.31 billion, a price-to-earnings ratio of 25.15 and a beta of 0.88. The firm has a 50 day moving average of $119.38 and a 200 day moving average of $116.51.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, April 27th. The financial services provider reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.02. The firm had revenue of $929 million for the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. Analysts expect that CME Group Inc will post $4.86 EPS for the current year.

Several equities analysts recently issued reports on CME shares. Deutsche Bank AG restated a “buy” rating and issued a $134.00 price target (down previously from $137.00) on shares of CME Group in a research report on Friday. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, March 8th. Jefferies Group LLC restated a “buy” rating and issued a $128.00 price target on shares of CME Group in a research report on Saturday, March 11th. JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 31st. Finally, Royal Bank of Canada dropped their target price on CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 19th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. CME Group presently has a consensus rating of “Hold” and an average price target of $111.29.

In other CME Group news, Director Ronald A. Pankau sold 500 shares of the company’s stock in a transaction on Friday, February 24th. The stock was sold at an average price of $122.11, for a total value of $61,055.00. Following the transaction, the director now owns 3,500 shares of the company’s stock, valued at approximately $427,385. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,043 shares of the company’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $124.26, for a total value of $378,123.18. Following the completion of the transaction, the insider now directly owns 26,082 shares in the company, valued at approximately $3,240,949.32. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,030 shares of company stock worth $1,702,964. Corporate insiders own 0.61% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Related Posts:

  • No Related Posts

CME Group (NASDAQ:CME) Raised to Strong-Buy at BidaskClub

CME Group (NASDAQ:CME) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Tuesday, March 27th. Several other equities research analysts have also weighed in on CME. Bank of America increased their price objective on …

CME Group logoCME Group (NASDAQ:CME) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Tuesday, March 27th.

Several other equities research analysts have also weighed in on CME. Bank of America increased their price objective on shares of CME Group from $175.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, March 8th. ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Zacks Investment Research lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Goldman Sachs upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price target on the stock in a research note on Wednesday, February 7th. Finally, Barclays raised their price target on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Three analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $165.57.

How to Become a New Pot Stock Millionaire

NASDAQ:CME traded down $0.74 on Tuesday, reaching $164.46. The stock had a trading volume of 1,318,109 shares, compared to its average volume of 1,729,481. The stock has a market cap of $56,081.83, a P/E ratio of 34.48, a PEG ratio of 2.29 and a beta of 0.56. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03. CME Group has a 12-month low of $114.82 and a 12-month high of $171.71.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.02. The business had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 EPS. equities analysts expect that CME Group will post 6.86 earnings per share for the current year.

In related news, insider Hilda Harris Piell sold 3,299 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Derek Sammann sold 2,400 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $161.66, for a total transaction of $387,984.00. Following the sale, the insider now owns 40,153 shares of the company’s stock, valued at $6,491,133.98. The disclosure for this sale can be found here. Insiders have sold 35,699 shares of company stock valued at $5,532,362 over the last 90 days. 0.57% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of CME. ARK Investment Management LLC acquired a new position in CME Group in the 4th quarter worth approximately $120,000. Valeo Financial Advisors LLC acquired a new position in CME Group in the 3rd quarter worth approximately $124,000. AlphaOne Investment Services LLC acquired a new position in CME Group in the 4th quarter worth approximately $146,000. Mosaic Family Wealth LLC acquired a new position in CME Group in the 4th quarter worth approximately $146,000. Finally, Truewealth LLC acquired a new position in CME Group in the 4th quarter worth approximately $157,000. 83.41% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “CME Group (NASDAQ:CME) Raised to Strong-Buy at BidaskClub” was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/04/19/cme-group-cme-upgraded-by-bidaskclub-to-strong-buy.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Synaptics, Incorporated (SYNA) Shares Rating Restated by Jefferies Group LLC

Norges Bank acquired a new position in shares of Synaptics, during the fourth quarter valued at approximately $31,600,000. Quentec Asset Management LLC acquired a new position in shares of Synaptics, during the third quarter valued at approximately $22,580,000. Crosslink Capital Inc. acquired a …

Synaptics, Incorporated (NASDAQ:SYNA)‘s stock had its “underperform” rating reiterated by analysts at Jefferies Group LLC in a report issued on Saturday. They currently have a $48.00 price target on the software maker’s stock, up from their previous price target of $45.00. Jefferies Group LLC’s target price indicates a potential downside of 12.36% from the stock’s previous close.

SYNA has been the subject of several other reports. BMO Capital Markets reiterated a “hold” rating and issued a $56.00 target price on shares of Synaptics, in a research note on Friday. Zacks Investment Research upgraded shares of Synaptics, from a “hold” rating to a “buy” rating and set a $57.00 target price for the company in a research note on Saturday, April 22nd. Cowen and Company reiterated an “outperform” rating and issued a $75.00 target price on shares of Synaptics, in a research note on Wednesday, March 22nd. Cann reiterated an “underperform” rating and issued a $45.00 target price on shares of Synaptics, in a research note on Tuesday, January 24th. Finally, Craig Hallum cut their target price on shares of Synaptics, from $65.00 to $62.00 and set a “hold” rating for the company in a research note on Friday. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $61.89.

Shares of Synaptics, (NASDAQ:SYNA) traded up 3.59% during mid-day trading on Friday, hitting $54.77. The stock had a trading volume of 2,212,803 shares. The company has a 50 day moving average price of $50.35 and a 200 day moving average price of $54.80. Synaptics, has a 12-month low of $47.00 and a 12-month high of $71.19. The firm has a market cap of $1.94 billion, a P/E ratio of 50.43 and a beta of 1.24.

Synaptics, (NASDAQ:SYNA) last posted its quarterly earnings data on Thursday, April 27th. The software maker reported $0.81 EPS for the quarter, missing the Zacks’ consensus estimate of $0.85 by $0.04. Synaptics, had a return on equity of 14.02% and a net margin of 2.54%. The business had revenue of $442.20 million for the quarter, compared to analyst estimates of $430.19 million. During the same quarter in the prior year, the company earned $1.21 earnings per share. The company’s quarterly revenue was up 9.9% on a year-over-year basis. Equities analysts forecast that Synaptics, will post $4.90 earnings per share for the current fiscal year.

In other news, insider Rick Bergman sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, February 10th. The shares were sold at an average price of $56.26, for a total transaction of $562,600.00. Following the transaction, the insider now directly owns 105,488 shares of the company’s stock, valued at $5,934,754.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Wajid Ali sold 477 shares of the firm’s stock in a transaction that occurred on Wednesday, February 1st. The stock was sold at an average price of $56.96, for a total transaction of $27,169.92. Following the transaction, the vice president now directly owns 17,627 shares in the company, valued at $1,004,033.92. The disclosure for this sale can be found here. 3.60% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in SYNA. Norges Bank acquired a new position in shares of Synaptics, during the fourth quarter valued at approximately $31,600,000. Quentec Asset Management LLC acquired a new position in shares of Synaptics, during the third quarter valued at approximately $22,580,000. Crosslink Capital Inc. acquired a new position in shares of Synaptics, during the fourth quarter valued at approximately $16,374,000. Peregrine Capital Management LLC acquired a new position in shares of Synaptics, during the third quarter valued at approximately $9,939,000. Finally, JPMorgan Chase & Co. boosted its position in shares of Synaptics, by 665.4% in the third quarter. JPMorgan Chase & Co. now owns 195,114 shares of the software maker’s stock valued at $11,429,000 after buying an additional 169,622 shares in the last quarter. 92.09% of the stock is currently owned by institutional investors.

About Synaptics,

Synaptics Incorporated is engaged in the development, marketing and sale of intuitive human interface solutions for electronic devices and products. The Company is a developer and supplier of custom-designed human interface product solutions that enable people to interact with a range of mobile computing, communications, entertainment and other electronic devices.

Related Posts:

  • No Related Posts

iRobot Co. (IRBT) Raised to “Purchase” at Zacks Investment Research

iRobot Co. (NASDAQ:IRBT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm currently has a $89.00 price objective on the industrial products company’s stock. Zacks Investment Research’s target price would suggest a potential …

iRobot Co. (NASDAQ:IRBT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm currently has a $89.00 price objective on the industrial products company’s stock. Zacks Investment Research’s target price would suggest a potential upside of 11.40% from the company’s current price.

According to Zacks, “Over the last three months, iRobot’s shares outperformed the Zacks categorized Industrial Automation/Robotics industry. The company reported better-than-expected first-quarter 2017 results. Quarterly adjusted earnings of $0.52 per share surpassed the Zacks Consensus Estimate by 100%. The upside was driven by stronger sales and improved margin. The company is well poised to boost its near-term top- and bottom-line performance on the back of higher home robotics demand, efficient marketing programs, as well as the latest Sales On Demand Corporation buyout. Notably, the new capital allocation program is likely to generate benefits in the quarters ahead.”

Several other equities research analysts also recently issued reports on the company. Canaccord Genuity reissued a “buy” rating and issued a $90.00 price objective on shares of iRobot in a research note on Wednesday. Needham & Company LLC reissued a “hold” rating on shares of iRobot in a research note on Saturday, April 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $65.71.

iRobot (NASDAQ:IRBT) traded down 0.6767% during trading on Friday, reaching $79.3494. 451,656 shares of the company were exchanged. The stock has a market capitalization of $2.17 billion, a PE ratio of 40.7966 and a beta of 1.15. The firm’s 50 day moving average is $64.50 and its 200 day moving average is $57.71. iRobot has a 52-week low of $33.90 and a 52-week high of $82.44.

iRobot (NASDAQ:IRBT) last announced its quarterly earnings data on Tuesday, April 25th. The industrial products company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.26. The firm earned $168.47 million during the quarter, compared to the consensus estimate of $155.86 million. iRobot had a return on equity of 11.14% and a net margin of 6.35%. The business’s revenue for the quarter was up 28.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.13 EPS. Analysts expect that iRobot will post $1.65 EPS for the current year.

In other news, CEO Colin M. Angle sold 9,857 shares of the firm’s stock in a transaction dated Tuesday, February 7th. The stock was sold at an average price of $63.41, for a total transaction of $625,032.37. Following the completion of the sale, the chief executive officer now directly owns 482,601 shares of the company’s stock, valued at approximately $30,601,729.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Alison Dean sold 7,375 shares of the firm’s stock in a transaction dated Friday, April 7th. The stock was sold at an average price of $66.59, for a total value of $491,101.25. Following the sale, the chief financial officer now directly owns 90,656 shares of the company’s stock, valued at $6,036,783.04. The disclosure for this sale can be found here. Over the last three months, insiders sold 26,717 shares of company stock valued at $1,741,100. Company insiders own 5.53% of the company’s stock.

Large investors have recently bought and sold shares of the company. Flinton Capital Management LLC purchased a new stake in iRobot during the fourth quarter worth $116,000. US Bancorp DE increased its stake in iRobot by 0.7% in the third quarter. US Bancorp DE now owns 2,293 shares of the industrial products company’s stock worth $101,000 after buying an additional 16 shares during the period. Victory Capital Management Inc. increased its stake in iRobot by 3.7% in the third quarter. Victory Capital Management Inc. now owns 2,451 shares of the industrial products company’s stock worth $108,000 after buying an additional 87 shares during the period. State of Alaska Department of Revenue increased its stake in iRobot by 2.4% in the first quarter. State of Alaska Department of Revenue now owns 3,010 shares of the industrial products company’s stock worth $199,000 after buying an additional 70 shares during the period. Finally, Lyell Wealth Management LP purchased a new stake in iRobot during the fourth quarter worth $234,000. 79.37% of the stock is owned by institutional investors.

iRobot Company Profile

iRobot Corporation is a consumer robot company, which is engaged in designing and building robots. The Company’s portfolio of solutions features various technologies for the connected home and various concepts in mapping, navigation, mobility and artificial intelligence. The Company sells various products that are designed for use at home.

Get a free copy of the Zacks research report on iRobot (IRBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related Posts:

  • No Related Posts

Today Analysts Focus on Snap Inc. (SNAP), NVIDIA Corporation (NVDA)

NVIDIA Corporation (NASDAQ:NVDA), maintained return on investment for the last twelve months at 32.13, higher than what Reuters data shows regarding industry’s average. The average of this ratio is 4.01 for the industry and sector’s best figure appears 17.32. NVIDIA Corporation (NASDAQ:NVDA), …

Snap Inc. (NYSE:SNAP) plunged -1.55% with the closing price of $14.65. The overall volume in the last trading session was 9.84 million shares.

Company Growth Evolution:

ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business. Investors who are keeping close eye on the stock of Snap Inc. (NYSE:SNAP) established that the company was able to keep return on investment at -131.38 in the trailing twelve month while Reuters data showed that industry’s average stands at 12.84 and sector’s optimum level is 17.32.

Analysts have a mean recommendation of 3.10 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell” within the 4 range, and “strong sell” within the 5 range). The stock appeared $23.57 above its 52-week highs and is down -1.01% for the last five trades. The stock ended last trade at 14.65 a share and the price is up more than 0.27% so far this year. The company maintains price to book ratio of 6.08 vs. an industry average at 6.73. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.



NVIDIA Corporation (NASDAQ:NVDA) ended its day at 236.37 with the rising stream of -0.49% and its total traded volume was 9.75 million shares less than the average volume.

Returns and Valuations for NVIDIA Corporation (NASDAQ:NVDA)

NVIDIA Corporation (NASDAQ:NVDA), maintained return on investment for the last twelve months at 32.13, higher than what Reuters data shows regarding industry’s average. The average of this ratio is 4.01 for the industry and sector’s best figure appears 17.32. NVIDIA Corporation (NASDAQ:NVDA), at its latest closing price of $236.37, it has a price-to-book ratio of 19.27, compared to an industry average at 2.36. A lower P/B ratio could mean that the stock is undervalued. This ratio also gives some idea of whether you’re paying too much for what would be left if the company went bankrupt immediately.

NVIDIA Corporation (NASDAQ:NVDA), stock is trading $254.50 above the 52-week high and has displayed a high EPS growth of 38.60% in last 5 years. The 1 year EPS growth rate is 79.60% . Its share price has risen 5.18% in three months and is up 4.48% for the last five trades. The average analysts gave this company a mean recommendation of 2.30.

Like this:

LikeLoading…

Related Posts:

  • No Related Posts